Sprix Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Sprix General Information

Description

Producer of pain reliever spray used in hospitals. The company's spray is a non-steroidal anti-inflammatory drug used as a short-term treatment for moderate to moderately severe pain that requires anaglesia at the opioid level.

Contact Information

Website
www.sprix.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • Regency Therapeutics, 1 Luitpold Drive
  • P.O. Box 9001
  • Shirley, NY 11967
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sprix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sprix‘s full profile, request access.

Request a free trial